Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2016-03-25 | Dr. Beckerle is a Distinguished Professor of Biology in the College of Science at the University of Utah, which she joined in 1986. Since 2006, Dr. Beckerle has served as Chief Executive Officer and Director of Huntsman Cancer Institute at the University of Utah. Dr. Beckerle served as President of the American Society for Cell Biology in 2006, held a Guggenheim Fellowship at the Curie Institute in Paris, and is an elected Fellow of the American Academy of Arts and Sciences. |
| 2017-03-22 | Dr. Beckerle is an internationally recognized scientist... Distinguished Professor of Biology... no mention of computer science or programming. |
| 2018-03-22 | Dr. Beckerle, age 63, has served as a director since May 2011. She serves as a member of the Audit Committee and the Governance Committee. Dr. Beckerle is an internationally recognized scientist who has served on numerous national scientific boards and committees, including the Advisory Committee to the Director of the U.S. National Institutes of Health. She currently serves on the Board of Directors of Johnson and Johnson, a publicly traded health care company. She is also a member of cancer policy and advisory boards at Harvard University, Georgetown University, the University of Pennsylvania, the National Center for Biological Sciences in Bangalore (India), and the Mechanobiology Institute of the National University of Singapore. Dr. Beckerle is a Distinguished Professor of Biology in the College of Science at the University of Utah, which she joined in 1986. Since 2006, Dr. Beckerle has served as Chief Executive Officer and Director of Huntsman Cancer Institute at the University of Utah. |
| 2019-03-22 | Dr. Beckerle, age 64, has served as one of our directors since May 2011. She is a member of our Audit Committee and our Governance Committee. Dr. Beckerle is an internationally recognized scientist who has served on numerous national scientific boards and committees, including the Advisory Committee to the Director of the U.S. National Institutes of Health. She is also a member of cancer policy and advisory boards at Harvard University, Georgetown University, the University of Pennsylvania, the National Center for Biological Sciences in Bangalore (India), and the Mechanobiology Institute of the National University of Singapore. She also serves as a director of Johnson & Johnson. Dr. Beckerle is a Distinguished Professor of Biology in the College of Science at the University of Utah, which she joined in 1986. Since 2006, Dr. Beckerle has served as Chief Executive Officer of Huntsman Cancer Institute at the University of Utah. |
| 2020-03-20 | Dr. Beckerle is a Distinguished Professor of Biology in the College of Science at the University of Utah. She served as President of the American Society for Cell Biology in 2006 and is an internationally recognized scientist. |
| 2021-03-18 | Dr. Mary Beckerle, 66, has served as a director since May 2011 and sits on both the Audit Committee and the Nominating and Corporate Governance Committee. She is an internationally recognized academic and research scientist who has served as Chief Executive Officer of the Huntsman Cancer Institute at the University of Utah since 2006... Her deep knowledge of chemical and other sciences utilized in the field of cancer treatment and research, her familiarity with regulatory affairs and compliance oversight associated with chemicals, pharmaceuticals, and medical devices, and her executive management experience at the Huntsman Cancer Institute enable her to provide valuable insight and guidance to the Board in all these areas. |
| 2023-03-21 | Mary C. Beckerle - Chief Executive Officer of University of Utah Huntsman Cancer Institute. Holds a B.A. in Biology and Psychology and a Ph.D. in Molecular, Cellular, and Developmental Biology. |
| 2024-03-22 | B. A. in Biology and Psychology, Ph.D. in Molecular, Cellular, and Developmental Biology; CEO of University of Utah Huntsman Cancer Institute. |
| 2025-03-17 | Chief Executive Officer of University of Utah Huntsman Cancer Institute; B. A. in Biology and Psychology, Wells College; Ph.D. in Molecular, Cellular, and Developmental Biology, University of Colorado Boulder; Post-doctoral fellow in Anatomy and Cell Biology, University of North Carolina Chapel Hill. |
| Filing Date | Source Excerpt |
|---|---|
| 2017-03-15 | Dr. Beckerle, 62, has served as CEO and Director of Huntsman Cancer Institute since 2006... Chairman, Science, Technology & Sustainability Committee; Member, Regulatory, Compliance & Government Affairs Committee... $294,452 total compensation. |
| 2018-03-14 | Dr. Beckerle, 63, has served as CEO and Director of Huntsman Cancer Institute since 2006... Chairman, Science, Technology & Sustainability Committee; Member, Regulatory, Compliance & Government Affairs Committee... 2017 Total Non-Employee Director Compensation: $324,893. |
| 2019-03-13 | Mary C. Beckerle, Ph.D. Independent Director Primary Occupation: Chief Executive Officer, Huntsman Cancer Institute at the University of Utah; Distinguished Professor of Biology, College of Science, University of Utah Current Committees: Chairman, Science, Technology & Sustainability; Member, Regulatory Compliance 2018 Total Non-Employee Director Compensation: $339,940 |
| 2020-03-11 | Dr. Beckerle, age 65, has served as Chief Executive Officer of the Huntsman Cancer Institute at the University of Utah since 2006. She is the Associate Vice President for Cancer Affairs and a Distinguished Professor of Biology and Oncological Sciences at the University of Utah. Dr. Beckerle joined the faculty of the University of Utah in 1986 and currently holds the Jon M. Huntsman Presidential Endowed Chair. Dr. Beckerle has served on the National Institute of Health (NIH) Advisory Committee to the Director, on the Board of Directors of the American Association for Cancer Research, as President of the American Society for Cell Biology and as the Chair of the American Cancer Society Council for Extramural Grants. She currently serves on a number of scientific advisory boards, including the Medical Advisory Board of the Howard Hughes Medical Institute, the Board of Scientific Advisors of the National Cancer Institute (USA) and the External Advisory Board of the Dana Farber/Harvard Cancer Center. Current Committees: Chair, Science, Technology & Sustainability; Member, Regulatory Compliance. 2019 Total Non-Employee Director Compensation: $344,979. |
| 2022-03-16 | M. C. Beckerle I 67 2015 Chief Executive Officer, Huntsman Cancer Institute; Distinguished Professor of Biology, College of Science, University of Utah Chair, Science, Technology & Sustainability Member, Regulatory Compliance 2021 Total Non-Employee Director Compensation $344,868 |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22